4D Molecular Therapeutics Inc — キャッシュフロー (NASDAQ:FDMT) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

営業活動によるキャッシュフロー -50.91 M-69.13 M-86.69 M-75.79 M-134.59 M-109.08 M -109.08 M 投資活動によるキャッシュフロー -1 M-172.68 M-17.05 M115.72 M-302.44 M-92.97 M -92.97 M 財務活動によるキャッシュフロー 278.98 M118.09 M3.08 M156.83 M337.25 M112.96 M — フリーキャッシュフロー -51.91 M-78.24 M-98.22 M-78.56 M-138.37 M-109.62 M -109.62 M

ニュース

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19

RBCキャピタル、4Dモレキュラー株に対し「アウトパフォーム」評価を32ドルで維持

RBC Capital reiterates Outperform rating on 4D Molecular stock at $32

4Dモレキュラー・セラピューティクスのアシュー・グプタ氏、FDMTの株式を330万ドル分売却

Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock

4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)

BlackBerry, FedEx, Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Aimei Health Technology (NASDAQ:AFJK), Aura Biosciences (NASDAQ:AURA)

Avago and Oracle among market cap stock movers on Wednesday

4D Molecular Therapeutics, Inc. (FDMT) Discusses Interim Phase I Data From AEROW Trial in Cystic Fibrosis and Platform Potential Transcript